Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elmar Bucher

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Genome Medicine|May 2, 2012
Metabolomics of human breast cancer: new approaches for tumor typing and biomarker discoveryCarsten Denkert, Elmar Bucher, Mika Hilvo, et al.
Plos One|March 3, 2011
GTI: a novel algorithm for identifying outlier gene expression profiles from integrated microarray datasetsJohn Patrick Mpindi, Henri Sara, Saija Haapa-Paananen, et al.
Cell Reports|January 1, 2026
Growth factors maintain intratumoral heterogeneity and drive therapeutic resistance in triple-negative breast cancerKaylyn L Devlin, Rebecca Smith, Elmar Bucher, et al.
The Journal of Clinical Investigation|December 1, 2025
Corrigendum to Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasisAntti Arjonen, Riina Kaukonen, Elina Mattila, et al.
The Journal of Clinical Investigation|February 4, 2014
Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasisAntti Arjonen, Riina Kaukonen, Elina Mattila, et al.
JCI Insight|January 14, 2025
Highly multiplexed imaging reveals prognostic immune and stromal spatial biomarkers in breast cancerJennifer R Eng, Elmar Bucher, Zhi Hu, et al.
Neuro-Oncology Advances|September 9, 2020
Transcriptional signatures in histologic structures within glioblastoma tumors may predict personalized drug sensitivity and survivalCymon N Kersch, Cheryl J Claunch, Prakash Ambady, et al.
Cell Systems|March 19, 2018
Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer SubtypesSpencer S Watson, Mark Dane, Koei Chin, et al.
Genome Biology|September 23, 2008
Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissuesSami Kilpinen, Reija Autio, Kalle Ojala, et al.
Journal of Proteome Research|June 1, 2022
Correction to "Integration of Metabolomics and Expression of Glycerol-3-phosphate Acyltransferase (GPAM) in Breast Cancer─Link to Patient Survival, Hormone Receptor Status, and Metabolic Profiling"Scarlet F Brockmöller, Elmar Bucher, Berit M Müller, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Genome Medicine|May 2, 2012
Metabolomics of human breast cancer: new approaches for tumor typing and biomarker discoveryCarsten Denkert, Elmar Bucher, Mika Hilvo, et al.
Plos One|March 3, 2011
GTI: a novel algorithm for identifying outlier gene expression profiles from integrated microarray datasetsJohn Patrick Mpindi, Henri Sara, Saija Haapa-Paananen, et al.
Cell Reports|January 1, 2026
Growth factors maintain intratumoral heterogeneity and drive therapeutic resistance in triple-negative breast cancerKaylyn L Devlin, Rebecca Smith, Elmar Bucher, et al.
The Journal of Clinical Investigation|December 1, 2025
Corrigendum to Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasisAntti Arjonen, Riina Kaukonen, Elina Mattila, et al.
The Journal of Clinical Investigation|February 4, 2014
Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasisAntti Arjonen, Riina Kaukonen, Elina Mattila, et al.
JCI Insight|January 14, 2025
Highly multiplexed imaging reveals prognostic immune and stromal spatial biomarkers in breast cancerJennifer R Eng, Elmar Bucher, Zhi Hu, et al.
Neuro-Oncology Advances|September 9, 2020
Transcriptional signatures in histologic structures within glioblastoma tumors may predict personalized drug sensitivity and survivalCymon N Kersch, Cheryl J Claunch, Prakash Ambady, et al.
Cell Systems|March 19, 2018
Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer SubtypesSpencer S Watson, Mark Dane, Koei Chin, et al.
Genome Biology|September 23, 2008
Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissuesSami Kilpinen, Reija Autio, Kalle Ojala, et al.
Journal of Proteome Research|June 1, 2022
Correction to "Integration of Metabolomics and Expression of Glycerol-3-phosphate Acyltransferase (GPAM) in Breast Cancer─Link to Patient Survival, Hormone Receptor Status, and Metabolic Profiling"Scarlet F Brockmöller, Elmar Bucher, Berit M Müller, et al.
Pageof 3